Evidence map›Paper›PMID 40380288›Full record

ReviewActa epileptologica2025

Research progress on epilepsy with myoclonic absence.

Fen Tang, Minting Li, Liangmin Liu, Xuemei Wang, Bing Qin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acta epileptologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fen TangEpilepsy Center, Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Minting LiEpilepsy Center, Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Liangmin LiuEpilepsy Center, Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Xuemei WangEpilepsy Center, Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Bing QinEpilepsy Center, Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China. qb900@163.com.

Funding

China Scholarship Council 201906785005Jinan University 89018041
6 · The paper itself

Abstract

Epilepsy with myoclonic absence (EMA) is a rare childhood-onset generalized epilepsy syndrome characterized by myoclonic absence seizures. First discovered by Tassinari et al. in 1969, EMA has been extensively studied by researchers from all over the world. This review synthesizes recent studies on EMA, covering its discovery history, classification, epidemiology, pathophysiology, etiology, clinical manifestations, diagnosis and differential diagnosis, treatment, prognosis and evolution, and especially discusses the etiology and pathophysiology mechanism, to help clinicians understand this relatively rare epilepsy syndrome, reduce the rate of missed diagnosis and misdiagnosis, and effectively guide treatment to alleviate the long-term cognitive impairment in affected individuals.

Indexed as

Epilepsy with myoclonic absenceGenetic etiologyPathophysiology

Identifiers

PMID40380288
PMCPMC12082880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.